Bradford Royal Infirmary is a large teaching hospital in Bradford, West Yorkshire, England, and is operated by the Bradford Teaching Hospitals NHS Foundation Trust. The infirmary is affiliated with the Leeds School of Medicine.

During the past decade, Bradford Royal Infirmary conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 13 clinical trials were completed, i.e. on average, 28.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bradford Royal Infirmary" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "University College, London" with 3 trials sponsored, "University of Edinburgh" with 3 trials sponsored and "Belfast Health and Social Care Trust" with 3 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bradford Royal Infirmary" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "NHS Lothian" with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Bradford Royal Infirmary" are "Diabetic Macular Edema" (6 trials), "Asthma" (4 trials), "Geographic Atrophy" (3 trials), "Multiple Myeloma" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Bradford Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Bradford Royal Infirmary" are "Drug" (54 trials), "Procedure" (17 trials), "Other" (11 trials), "Biological" (10 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Sham Procedure" (5 trials), "adjuvant therapy" (4 trials), "capecitabine" (4 trials) and "Faricimab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bradford Royal Infirmary" are 73 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bradford Royal Infirmary". undefined are not yet recruiting, 11 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Bradford Royal Infirmary, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Bradford Royal Infirmary, 3 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".